Question 1

What is the catalog number for Compound T129194?

Accepted Answer

The catalog number for Compound T129194 is orb3171423.

Question 2

What sizes are available for Compound T129194?

Accepted Answer

Compound T129194 is available in the following size(s): 1 mg, 2 mg, 3 mg, 4 mg, 5 mg.

Question 3

How many pack sizes does Compound T129194 come in?

Accepted Answer

Compound T129194 is available in 5 different pack sizes.

Question 4

Is Compound T129194 in stock?

Accepted Answer

Compound T129194 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is Compound T129194 used for?

Accepted Answer

1-{7,9,10-trihydroxy-9a,11a-dimethyl-3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl}ethan-1-one is a high-purity biochemical reagent suitable for biochemical experiments and drug synthesis research.

Question 6

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Question 7

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 8

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

Compound T129194

Product Specifications

Smiles

Molecular Formula

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

Lirentelimab (Biosimilar Reference Antibody) (SIGLEC8)

Lirentelimab (Biosimilar Reference Antibody) (SIGLEC8)

Lirentelimab (Biosimilar Reference Antibody) (SIGLEC8)

Lirentelimab (Biosimilar Reference Antibody) (SIGLEC8)

Lirentelimab (Biosimilar Reference Antibody) (SIGLEC8)

Lirentelimab (Biosimilar Reference Antibody) (SIGLEC8)